Bio-Gate AG · ISIN: DE000BGAG981 · EQS - Company News

Bio-Gate AG signs LOI with North American medical device manufacturer for trauma implants

  PRESS INFORMATION   Bio-Gate AG signs LOI with North American medical device manufacturer for trauma implants   Nuremberg/Bremen, July 31, 2023 - Bio-Gate AG (ISIN DE000BGAG981), a leading provider of innovative technologies and individual solutions for health and hygiene, has concluded a preliminary agreement (LOI, Letter-of-Intent) with a North American medical device manufacturer focusing on the trauma sector. The medical device manufacturer intends to use Bio-Gate's "HyProtectTM" coat...

XETR:BIG1 Price indication powered by TradingView

About the publication

Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor

Smart tools for smart investors can be found in our Tools section

Corporate News Bio-Gate AG

In this overview you can view company news in the chronological order of publication. The source information comes from EQS News, the leading European news distributor. The most recent news item is listed first.
Back to Corporate News Overview
This might be interesting for you as well
Analyst Ratings (0)
Directors Dealings (5)
Short Selling (DE) (0)
Short Selling (UK) (0)
31 July 2023 05:01PM
Bio-Gate AG signs LOI with North American medical device manufacturer for trauma implants
DE000BGAG981
  PRESS INFORMATION   Bio-Gate AG signs LOI with North American medical device manufacturer for trauma implants   Nuremberg/Bremen, July 31, 2023 - Bio-Gate AG (ISIN DE000BGAG981), a leading provider of innovative technologies and individual solutions for health and hygiene, has concluded a preliminary agreement (LOI, Letter-of-Intent) with a ...
Bio-Gate AG
About the publication
31 July 2023 05:01PM
Bio-Gate AG signs LOI with North American medical device manufacturer for trauma implants
DE000BGAG981
  PRESS INFORMATION   Bio-Gate AG signs LOI with North American medical device manufacturer for trauma implants   Nuremberg/Bremen, July 31, 2023 - Bio-Gate AG (ISIN DE000BGAG981), a leading provider of innovative technologies and individual solutions for health and hygiene, has concluded a preliminary agreement (LOI, Letter-of-Intent) with a ...
Bio-Gate AG
About the publication
28 October 2020 09:00AM
Bio-Gate AG: Bio-Gate successfully markets antiviral and antibacterial Protective Film Spray for surfaces
DE000BGAG981
PRESS RELEASEBio-Gate successfully markets antiviral and antibacterial Protective Film Spray for surfaces - Protective Film Spray from Bio-Gate used for the first time in public transport in Nuremberg - Advanced negotiations with further potential customers - Successful commercialization for use in schools, public transport, banks and fitness studi...
Bio-Gate AG
About the publication
More Bio-Gate AG related information
Type Total Last Made by Go to
Corporate Research 0 - - Corporate Research
Directors Dealings 5 23rd November 2023 Richter, Karl DD
Short Seller (DE) 0 - - SSR (DE)
Short Seller (UK) 0 - - SSR (UK)
Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.

v.07062023 EN